Microdermics
Vancouver · British Columbia, Canada corporation · 1 known investors
Microdermics develops a metal, hollow microneedle injection platform intended to replace traditional hypodermic needles for drug delivery. The company targets the biotherapeutics market with a scalable and customizable microneedle technology.
Founders & leadership
BS
Boris StoeberFounder
LJ
Lana JanesNamed on SEC filing
RC
Ray ChanNamed on SEC filing
TF
Todd FarrellNamed on SEC filing
FD
Francis DuhayNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$492.6KofferedJan 2020 · 1 investors · OtherRule 506(b)
▶$492.6KofferedJan 2020 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Lana JanesDirector
- Ray ChanDirector
- Boris StoeberExecutive Officer, Director
- Todd FarrellDirector
- Francis DuhayExecutive Officer, Director
- Offering amount
- $492.6K
- First sale
- Dec 2019
- Incorporated
- Corporation, British Columbia, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Microdermics do?
- Microdermics develops a metal, hollow microneedle injection platform intended to replace traditional hypodermic needles for drug delivery. The company targets the biotherapeutics market with a scalable and customizable microneedle technology.
- Who founded Microdermics?
- Microdermics was founded by Boris Stoeber.
- Who are Microdermics's investors?
- Microdermics's investors include Shoreline Venture Management.
- Where is Microdermics headquartered?
- Microdermics is headquartered in Vancouver.